ME/CFS Science @mecfsscience.org · 15/05/20254) Data on prevalence of ME/CFS comes from the National Association of Statutory Health Insurance Physicians (KBV). For a population of approximately 80 million, the pre-pandemic prevalence was around 0.5%, so in line with other estimates. 130
ME/CFS Science @mecfsscience.org · 15/05/20255) Their estimate for the economic cost (30 billion or ca. 0.7% of GDP for ME/CFS in 2024) are higher than previous ones, but it’s likely that previous ones were underestimates. 120
ME/CFS Science @mecfsscience.org · 15/05/20256) Table 3 gives a useful comparison. The 2008 Jason et al. estimate is commonly used as a reference but it found a cost of only around 0.15% of GDP which seems quite low. The EUROMENE estimate (Pheby et al. 2020) used €40 billion or around 0.3% of GDP. 130
